针对中枢神经系统淋巴瘤的CAR T细胞疗法
Caroline Houillier1, Sylvain Choquet2
1Neurooncology Department, Groupe Hospitalier Pitié-Salpêtrière, APHP, Sorbonne Université, Inserm, CNRS, UMR S 1127, ICM, IHU, Paris, France. caroline.houillier@aphp.fr.
Current oncology reports
|October 28, 2024
概括
化学抗原受体 (CAR) T细胞疗法显示了中枢神经系统 (CNS) 淋巴瘤的高响应率. 尽管存在神经毒性问题,但该疗法对中枢神经系统淋巴瘤具有可控的安全性,具有前景.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 抗CD19CAR T细胞疗法对全身扩散大B细胞淋巴瘤有效.
- 以前,由于对神经毒性的担忧,中枢神经系统 (CNS) 淋巴瘤被排除在试验之外.
研究的目的:
- 评估CAR T细胞治疗中枢神经系统淋巴瘤的疗效和安全性.
- 审查最近关于CAR T细胞治疗初级和二级中枢神经系统淋巴瘤的研究.
主要方法:
- 对中枢神经系统淋巴瘤的CAR-T细胞治疗发表的研究进行系统审查.
- 分析反应率,无进展生存 (PFS) 和神经毒性.
主要成果:
- 在重度预先治疗的中枢神经系统淋巴瘤患者中观察到高响应率 (32-67%的完整响应).
- 在多项研究中报告的一年PFS率为40-60%.
- 神经毒性发生在36-68%的患者中,重度 (3-4级) 神经毒性发生在4.5-29%的患者中.
结论:
- 卡尔T细胞疗法在中枢神经系统淋巴瘤中显示出有前途的疗效,与全身淋巴瘤相似.
- 观察到的毒性概况,包括神经毒性,是可以管理的,并支持中枢神经系统淋巴瘤的进一步发展.
相关概念视频
Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K


